Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Safety and Tolerability of Ubrogepant for the Acute Treatment of Migraine in Participants Taking Atogepant for the Preventive Treatment of Episodic Migraine: Results from the TANDEM Trial

              Author:Brand-Schieber, Elimor   Lipton, Richard   Blumenfeld, Andrew   Yizeng He, Molly   Smith, Jonathan   Trugman, Joel   de Abreu Ferreira, Rosa   Ailani, Jessica   

              Session Name:S22: Advances in Migraine and Therapeutics  

              Topic:Headache  

              Program Number:S22.005  

              Author Institution:AbbVie, Madison, NJ  Albert Einstein College of Medicine, Bronx, NY  Headache Center of Southern California, Carlsbad, CA  AbbVie, North Chicago, IL  Georgetown University Hospital, McLean, VA  

              Cerebrospinal Fluid and Plasma Concentrations of Ubrogepant in Participants with a History of Migraine

              Author:Boinpally, Ramesh   Trugman, Joel   

              Session Name:P5: Headache: Advances in CGRP Inhibition 1  

              Topic:Headache  

              Program Number:P5.008  

              Author Institution:AbbVie, North Chicago, IL  Abbvie, Moraga, CA